白内障手术诱发新生血管性青光眼1例

1　临床资料患者 ,女 ,71岁 ,于 2 0 0 0年 9月 16日在表麻下行右眼超声乳化加人工晶状体植入术 ,术前血尿常规均正常 ,心电图 :下壁心肌缺血 ,频发房早 ,高血压病史 1a,全身检查未见手术禁忌症。血压 :2 4/ 12 k Pa。眼科检查 :视力 :R:数指 /眼前 ,L :0 .0 5 ,光定位和色觉正常 ,右眼角膜透明 ,前房正常深浅 ,虹膜纹理清 ,晶状体皮质性混浊 ,后囊混浊 ,眼压 :双眼2 0 .5 5 mm Hg(1k Pa=7.5 mm Hg)。术时 12 min,术中顺利 ,术后无不良反应 ,术后 1d,VA∶ R手动 ,结膜充血 ,切口平整 ,角膜透明 ,虹膜纹理清 ,人工晶状体在位 ,其上可见散…     

新生儿有机磷中毒诊为消化道出血1例

患儿女,22天,因呕吐鲜血3次,哭闹、烦躁不安2小时入院。入院前曾去乡镇卫生院,诊断为上消化道出血,支气管肺炎。给予青霉素、氧哌嗪青霉素、维生素K_1(具体不详)治疗,病情未见好转,急转入我院。家长否认有农药接触史。查体:T 37.1℃,P 114次/分,R 56次/分。神志清,精神萎靡,面色     

血管免疫母细胞性T细胞淋巴瘤临床特点及疗效分析

回顾性分析本院单中心近年收治的血管免疫母细胞性T细胞淋巴瘤（AITL）的临床特点及常规化疗近期疗效。方法:1999年9月～2010年9月于本院明确诊断AITL患者23例,其中21例接受治疗。初次治疗17例予CHOP样或CHOP方案,4例予左旋门冬酰胺酶＋博莱霉素＋地塞米松＋长春地辛方案;化疗后予受累野照射每组各1例,予自体造血干细胞移植巩固治疗每组各1例。复发后予ICE、DHAP或ProMACE/CytaBOM方案化疗。维持治疗采用干扰素或联合沙利度胺治疗者5例,采用西达苯胺者3例。结果:发病中位年龄60岁,男 :女为1.9:1,Ann Arbor Ⅲ～Ⅳ期占96%,57%患者有B组症状,22%患者合并脾受侵/脾肿大。实验室检查结果示,39%患者乳酸脱氢酶升高,75%患者β2微球蛋白升高,80%患者D-二聚体升高。病理组织免疫组化结果显示,CXCL13阳性率100%（12/12）,EBER阳性率80%（8/10）。疗效结果分析,CHOP样方案组7例获CR,8例获PR;含左旋门冬酰胺酶方案组1例获CR,1例获PR。21例患者中位生存27（2.9～51.1）个月,3年、5年总生存率分别为44%、29%。化疗后90％患者出现Ⅲ～Ⅳ度骨髓抑制,33％患者出现肺部感染,1例患者发生带状疱疹。结论:AITL为具有独特临床病理和生物学行为的外周T细胞肿瘤,多数患者同时存在凝血机制异常。AITL患者因并发免疫功能异常,化疗后骨髓抑制及感染问题不容忽视。      

反相高效液相色谱法测定人字草中槲皮素和木犀草素的含量

目的建立人字草中槲皮素和木犀草素含量测定方法。方法采用反相高效液相色谱(RP-HPLC)法,色谱柱为Zorbax SB-C18柱(4.6mm×250mm,5μm);检测波长360nm,流动相为甲醇-0.2%磷酸(50∶50),柱温30℃,流速1.0mL/min。结果槲皮素、木犀草素的回归方程分别为Y=2545.36X+86.37,Y=3261.65X+61.29;r分别为0.9995和0.9991;质量浓度线性范围分别是5.28-26.4μg/mL,4.12-20.6μg/mL;槲皮素、木犀草素的加样回收率分别为101.5%和99.6%,RSD分别为1.2%和0.83%;样品分别含槲皮素、木犀草素2.33mg/g,0.316mg/g。结论该方法适合同时测定人字草中槲皮素和木犀草素的含量,方法简便可行,重复性好,结果可靠。     

43例淋巴母细胞淋巴瘤患者临床特点及疗效分析

Objective To investigate the clinical features and treatment outcomes of different regimens in Chinese patients with lymphoblastic lymphoma(LBL). Methods Forty-three patients with LBL were retrospectively analysed, of which 30 were T-LBL, and 13 B-LBL. Results ①Most patients were young men with a median age of 21, and 63.0％ of the T-LBL patients had mediastinal masses. ② Treatment outcome could be assessed in 37 cases, of which the response rate (RR) was 81.1％ and complete remission (CR) rate was 67.6％. The RR and CR rates in patients treated with regimens for ALL (ALL-like group) and those treated with regimens for NHL(NHL-like group) were 94.4％ , 68.4％ and 83.3％ , 52.6％ , respectively. ③The estimated median overal survival(OS) and progression free survival (PFS) of hematopoietic stem cell transplantation (HSCT) group were significant longer than those of ALL-like group(P =0.018, P=0.025) and NHL-like group(P = 0. 016, P = 0. 011). The OS at 5 years in NHL-like group, ALL-like group and HSCT group were (14.4 ± 9.4) ％ , (20.2 ± 12.7) ％ and (79.5 ± 13.1) ％, respectively. Conclusion ①LBL is more common in young men, with less involvement of peripheral blood. Compared with B-LBL, T-LBL often has a mediastinal mass and serious cavity effusion. ② Intensive treatment regimens for ALL should be used in LBL. HSCT at CR1 can improve outcome obviously.     

43例淋巴母细胞淋巴瘤患者临床特点及疗效分析

Objective To investigate the clinical features and treatment outcomes of different regimens in Chinese patients with lymphoblastic lymphoma(LBL). Methods Forty-three patients with LBL were retrospectively analysed, of which 30 were T-LBL, and 13 B-LBL. Results ①Most patients were young men with a median age of 21, and 63.0％ of the T-LBL patients had mediastinal masses. ② Treatment outcome could be assessed in 37 cases, of which the response rate (RR) was 81.1％ and complete remission (CR) rate was 67.6％. The RR and CR rates in patients treated with regimens for ALL (ALL-like group) and those treated with regimens for NHL(NHL-like group) were 94.4％ , 68.4％ and 83.3％ , 52.6％ , respectively. ③The estimated median overal survival(OS) and progression free survival (PFS) of hematopoietic stem cell transplantation (HSCT) group were significant longer than those of ALL-like group(P =0.018, P=0.025) and NHL-like group(P = 0. 016, P = 0. 011). The OS at 5 years in NHL-like group, ALL-like group and HSCT group were (14.4 ± 9.4) ％ , (20.2 ± 12.7) ％ and (79.5 ± 13.1) ％, respectively. Conclusion ①LBL is more common in young men, with less involvement of peripheral blood. Compared with B-LBL, T-LBL often has a mediastinal mass and serious cavity effusion. ② Intensive treatment regimens for ALL should be used in LBL. HSCT at CR1 can improve outcome obviously.     

43例淋巴母细胞淋巴瘤患者临床特点及疗效分析

Objective To investigate the clinical features and treatment outcomes of different regimens in Chinese patients with lymphoblastic lymphoma(LBL). Methods Forty-three patients with LBL were retrospectively analysed, of which 30 were T-LBL, and 13 B-LBL. Results ①Most patients were young men with a median age of 21, and 63.0％ of the T-LBL patients had mediastinal masses. ② Treatment outcome could be assessed in 37 cases, of which the response rate (RR) was 81.1％ and complete remission (CR) rate was 67.6％. The RR and CR rates in patients treated with regimens for ALL (ALL-like group) and those treated with regimens for NHL(NHL-like group) were 94.4％ , 68.4％ and 83.3％ , 52.6％ , respectively. ③The estimated median overal survival(OS) and progression free survival (PFS) of hematopoietic stem cell transplantation (HSCT) group were significant longer than those of ALL-like group(P =0.018, P=0.025) and NHL-like group(P = 0. 016, P = 0. 011). The OS at 5 years in NHL-like group, ALL-like group and HSCT group were (14.4 ± 9.4) ％ , (20.2 ± 12.7) ％ and (79.5 ± 13.1) ％, respectively. Conclusion ①LBL is more common in young men, with less involvement of peripheral blood. Compared with B-LBL, T-LBL often has a mediastinal mass and serious cavity effusion. ② Intensive treatment regimens for ALL should be used in LBL. HSCT at CR1 can improve outcome obviously.     

不同配伍比例金银花-连翘药对合煎颗粒与单煎颗粒混合的化学成分比较

目的 比较不同配伍比例金银花-连翘药对合煎颗粒与单煎颗粒混合后的化学成分差异。方法 采集不同配伍比例金银花-连翘药对（1∶2、1∶1、3∶2、2∶1、3∶1）合煎颗粒及单煎颗粒混合后样品的高效液相色谱指纹图谱，并采用SPSS 26.0对指纹图谱各共有峰的峰面积/称样量值进行独立样本t检验分析。结果 指纹图谱中确定了15个共有峰，并对其中9个特征峰进行了指认。独立样本t检验结果显示，当金银花、连翘配伍比例为1∶2、1∶1时，合煎颗粒与单煎颗粒混合样品中各色谱峰峰面积/称样量值的差异无统计学意义；当金银花、连翘配伍比例为3∶2时，合煎颗粒与单煎颗粒混合样品中峰3、8、10、12的峰面积/称样量值差异有统计学意义（P<0.05）；当金银花、连翘配伍比例为2∶1时，合煎颗粒与单煎颗粒混合样品中除峰8外，其余14个特征峰的峰面积/称样量值差异无统计学意义；当金银花、连翘配伍比例为3∶1时，合煎颗粒与单煎颗粒混合样品指纹图谱的差异最大，除峰4、6、8外，其余12个特征峰的峰面积/称样量值差异有统计学意义（P<0.05）。结论 不同配伍比例金银花-连翘药对合煎颗粒与单煎颗粒混合的化学成分存在差异。